Annual Net Income
-$614.93 M
-$536.15 M-680.54%
31 December 2023
Summary:
Summit Therapeutics annual net profit is currently -$614.93 million, with the most recent change of -$536.15 million (-680.54%) on 31 December 2023. During the last 3 years, it has fallen by -$562.23 million (-1066.91%). SMMT annual net income is now -5757.63% below its all-time high of $10.87 million, reached on 31 January 2019.SMMT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$56.25 M
+$4.13 M+6.84%
30 September 2024
Summary:
Summit Therapeutics quarterly net profit is currently -$56.25 million, with the most recent change of +$4.13 million (+6.84%) on 30 September 2024. Over the past year, it has dropped by -$34.99 million (-164.50%). SMMT quarterly net income is now -260.81% below its all-time high of $34.98 million, reached on 31 July 2018.SMMT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$196.68 M
-$34.99 M-21.64%
30 September 2024
Summary:
Summit Therapeutics TTM net profit is currently -$196.68 million, with the most recent change of -$34.99 million (-21.64%) on 30 September 2024. Over the past year, it has increased by +$400.91 million (+67.09%). SMMT TTM net income is now -1482.57% below its all-time high of $14.23 million, reached on 01 April 2019.SMMT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SMMT Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -680.5% | -164.5% | +67.1% |
3 y3 years | -1066.9% | -187.0% | -162.1% |
5 y5 years | -5757.6% | -520.3% | -663.4% |
SMMT Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -1066.9% | at low | -282.2% | +89.6% | -162.1% | +68.0% |
5 y | 5 years | -5757.6% | at low | -817.1% | +89.6% | -815.8% | +68.0% |
alltime | all time | -5757.6% | at low | -260.8% | +89.6% | -1482.6% | +68.0% |
Summit Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$56.25 M(-6.8%) | -$196.68 M(+21.6%) |
June 2024 | - | -$60.38 M(+38.9%) | -$161.69 M(+39.4%) |
Mar 2024 | - | -$43.47 M(+18.9%) | -$116.03 M(-81.1%) |
Dec 2023 | -$614.93 M(+680.5%) | -$36.57 M(+71.9%) | -$614.93 M(+2.9%) |
Sept 2023 | - | -$21.27 M(+44.5%) | -$597.59 M(-0.0%) |
June 2023 | - | -$14.72 M(-97.3%) | -$597.71 M(-0.3%) |
Mar 2023 | - | -$542.38 M(+2720.6%) | -$599.76 M(+661.3%) |
Dec 2022 | -$78.78 M(-11.1%) | -$19.23 M(-10.1%) | -$78.78 M(-9.1%) |
Sept 2022 | - | -$21.39 M(+27.5%) | -$86.65 M(+2.1%) |
June 2022 | - | -$16.77 M(-21.6%) | -$84.87 M(-8.3%) |
Mar 2022 | - | -$21.40 M(-21.0%) | -$92.51 M(+4.4%) |
Dec 2021 | -$88.60 M(+68.1%) | -$27.10 M(+38.3%) | -$88.60 M(+18.1%) |
Sept 2021 | - | -$19.60 M(-19.7%) | -$75.04 M(+2.5%) |
June 2021 | - | -$24.42 M(+39.6%) | -$73.19 M(+14.3%) |
Mar 2021 | - | -$17.49 M(+29.1%) | -$64.05 M(+21.5%) |
Dec 2020 | -$52.70 M(+80.9%) | - | - |
Dec 2020 | - | -$13.54 M(-23.7%) | -$52.70 M(+34.6%) |
Sept 2020 | - | -$17.74 M(+16.1%) | -$39.16 M(+28.5%) |
June 2020 | - | -$15.28 M(+149.1%) | -$30.48 M(+41.9%) |
Mar 2020 | - | -$6.13 M(-32.4%) | -$21.48 M(-16.6%) |
Dec 2019 | -$29.13 M(-368.0%) | - | - |
Oct 2019 | - | -$9.07 M(+44.6%) | -$25.76 M(-4.7%) |
July 2019 | - | -$6.27 M(+20.5%) | -$27.03 M(-290.0%) |
Apr 2019 | - | -$5.20 M(-0.2%) | $14.23 M(+24.9%) |
Jan 2019 | $10.87 M(-138.1%) | - | - |
Jan 2019 | - | -$5.22 M(-49.5%) | $11.39 M(-7051.5%) |
Oct 2018 | - | -$10.34 M(-129.5%) | -$163.80 K(-101.8%) |
July 2018 | - | $34.98 M(-534.9%) | $9.03 M(-129.8%) |
Apr 2018 | - | -$8.04 M(-52.0%) | -$30.26 M(+6.7%) |
Jan 2018 | -$28.53 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jan 2018 | - | -$16.77 M(+1367.1%) | -$28.38 M(+55.6%) |
Oct 2017 | - | -$1.14 M(-73.5%) | -$18.24 M(-19.6%) |
July 2017 | - | -$4.31 M(-30.0%) | -$22.69 M(-15.6%) |
Apr 2017 | - | -$6.16 M(-7.2%) | -$26.88 M(-6.2%) |
Jan 2017 | -$26.71 M(-6.9%) | - | - |
Jan 2017 | - | -$6.63 M(+18.5%) | -$28.66 M(-6.4%) |
Oct 2016 | - | -$5.60 M(-34.1%) | -$30.63 M(-7.8%) |
July 2016 | - | -$8.49 M(+6.9%) | -$33.20 M(+7.1%) |
Apr 2016 | - | -$7.94 M(-7.6%) | -$31.00 M(+9.7%) |
Jan 2016 | -$28.68 M(+67.2%) | - | - |
Jan 2016 | - | -$8.60 M(+5.2%) | -$28.25 M(+20.5%) |
Oct 2015 | - | -$8.17 M(+29.8%) | -$23.44 M(+22.2%) |
July 2015 | - | -$6.29 M(+21.2%) | -$19.19 M(+4.0%) |
Apr 2015 | - | -$5.19 M(+37.0%) | -$18.45 M(+4.4%) |
Jan 2015 | -$17.15 M(+70.7%) | - | - |
Jan 2015 | - | -$3.79 M(-3.2%) | -$17.67 M(-0.8%) |
Oct 2014 | - | -$3.91 M(-29.5%) | -$17.81 M(+6.3%) |
July 2014 | - | -$5.55 M(+25.7%) | -$16.75 M(+49.5%) |
Apr 2014 | - | -$4.41 M(+12.2%) | -$11.21 M(+65.0%) |
Jan 2014 | -$10.05 M(+50.6%) | - | - |
Jan 2014 | - | -$3.93 M(+37.7%) | -$6.79 M(+137.7%) |
Oct 2013 | - | -$2.86 M | -$2.86 M |
Jan 2013 | -$6.67 M(+57.7%) | - | - |
Jan 2012 | -$4.23 M(-43.0%) | - | - |
Jan 2011 | -$7.42 M(-14.3%) | - | - |
Jan 2010 | -$8.66 M(-73.2%) | - | - |
Jan 2009 | -$32.29 M(+60.4%) | - | - |
Jan 2008 | -$20.13 M(+239.8%) | - | - |
Jan 2007 | -$5.92 M(+212.5%) | - | - |
Jan 2006 | -$1.90 M(+2089.1%) | - | - |
Jan 2005 | -$86.60 K | - | - |
FAQ
- What is Summit Therapeutics annual net profit?
- What is the all time high annual net income for Summit Therapeutics?
- What is Summit Therapeutics annual net income year-on-year change?
- What is Summit Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Summit Therapeutics?
- What is Summit Therapeutics quarterly net income year-on-year change?
- What is Summit Therapeutics TTM net profit?
- What is the all time high TTM net income for Summit Therapeutics?
- What is Summit Therapeutics TTM net income year-on-year change?
What is Summit Therapeutics annual net profit?
The current annual net income of SMMT is -$614.93 M
What is the all time high annual net income for Summit Therapeutics?
Summit Therapeutics all-time high annual net profit is $10.87 M
What is Summit Therapeutics annual net income year-on-year change?
Over the past year, SMMT annual net profit has changed by -$536.15 M (-680.54%)
What is Summit Therapeutics quarterly net profit?
The current quarterly net income of SMMT is -$56.25 M
What is the all time high quarterly net income for Summit Therapeutics?
Summit Therapeutics all-time high quarterly net profit is $34.98 M
What is Summit Therapeutics quarterly net income year-on-year change?
Over the past year, SMMT quarterly net profit has changed by -$34.99 M (-164.50%)
What is Summit Therapeutics TTM net profit?
The current TTM net income of SMMT is -$196.68 M
What is the all time high TTM net income for Summit Therapeutics?
Summit Therapeutics all-time high TTM net profit is $14.23 M
What is Summit Therapeutics TTM net income year-on-year change?
Over the past year, SMMT TTM net profit has changed by +$400.91 M (+67.09%)